5 employees
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,
2015
$10M
from 3 investors over 3 rounds
NovaGo Therapeutics raised $10M on March 4, 2019
Investors: Pureos Bioventures, Neurimmune AG and Kinled Holding Ltd